These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 38741835)
21. Determinants of Treatment Outcome, Follow-Up, and Abstinence Rates Among Patients With Alcohol Use Disorder: A Prospective Study. Gc M; Sankaran A; Subramanian K; Subramanian E Cureus; 2022 Nov; 14(11):e31356. PubMed ID: 36514662 [TBL] [Abstract][Full Text] [Related]
22. Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study. Addolorato G; Caputo F; Capristo E; Domenicali M; Bernardi M; Janiri L; Agabio R; Colombo G; Gessa GL; Gasbarrini G Alcohol Alcohol; 2002; 37(5):504-8. PubMed ID: 12217947 [TBL] [Abstract][Full Text] [Related]
23. Comparison of acamprosate and placebo in long-term treatment of alcohol dependence. Whitworth AB; Fischer F; Lesch OM; Nimmerrichter A; Oberbauer H; Platz T; Potgieter A; Walter H; Fleischhacker WW Lancet; 1996 May; 347(9013):1438-42. PubMed ID: 8676626 [TBL] [Abstract][Full Text] [Related]
24. Impact of depressive symptoms on future alcohol use in patients with co-occurring bipolar disorder and alcohol dependence: a prospective analysis in an 8-week randomized controlled trial of acamprosate. Prisciandaro JJ; DeSantis SM; Chiuzan C; Brown DG; Brady KT; Tolliver BK Alcohol Clin Exp Res; 2012 Mar; 36(3):490-6. PubMed ID: 21933201 [TBL] [Abstract][Full Text] [Related]
26. Acamprosate and relapse prevention in the treatment of alcohol dependence: a placebo-controlled study. Tempesta E; Janiri L; Bignamini A; Chabac S; Potgieter A Alcohol Alcohol; 2000; 35(2):202-9. PubMed ID: 10787398 [TBL] [Abstract][Full Text] [Related]
27. Opioid antagonists for alcohol dependence. Srisurapanont M; Jarusuraisin N Cochrane Database Syst Rev; 2005 Jan; (1):CD001867. PubMed ID: 15674887 [TBL] [Abstract][Full Text] [Related]
28. Moderation of baclofen response by a GABA Morley KC; Luquin N; Baillie A; Fraser I; Trent RJ; Dore G; Phung N; Haber PS Addiction; 2018 Dec; 113(12):2205-2213. PubMed ID: 29968397 [TBL] [Abstract][Full Text] [Related]
29. Pharmacologically induced alcohol craving in treatment seeking alcoholics correlates with alcoholism severity, but is insensitive to acamprosate. Umhau JC; Schwandt ML; Usala J; Geyer C; Singley E; George DT; Heilig M Neuropsychopharmacology; 2011 May; 36(6):1178-86. PubMed ID: 21289601 [TBL] [Abstract][Full Text] [Related]
30. Baclofen for alcohol dependence: a preliminary open-label study. Flannery BA; Garbutt JC; Cody MW; Renn W; Grace K; Osborne M; Crosby K; Morreale M; Trivette A Alcohol Clin Exp Res; 2004 Oct; 28(10):1517-23. PubMed ID: 15597084 [TBL] [Abstract][Full Text] [Related]
31. Repurposing drugs for treatment of alcohol use disorder. Aubin HJ Int Rev Neurobiol; 2024; 175():153-185. PubMed ID: 38555115 [TBL] [Abstract][Full Text] [Related]
32. Clinical experience of baclofen in alcohol dependence: A chart review. Rozatkar AR; Kapoor A; Sidana A; Chavan BS Ind Psychiatry J; 2016; 25(1):11-16. PubMed ID: 28163402 [TBL] [Abstract][Full Text] [Related]
33. New Australian guidelines for the treatment of alcohol problems: an overview of recommendations. Haber PS; Riordan BC; Winter DT; Barrett L; Saunders J; Hides L; Gullo M; Manning V; Day CA; Bonomo Y; Burns L; Assan R; Curry K; Mooney-Somers J; Demirkol A; Monds L; McDonough M; Baillie AJ; Clark P; Ritter A; Quinn C; Cunningham J; Lintzeris N; Rombouts S; Savic M; Norman A; Reid S; Hutchinson D; Zheng C; Iese Y; Black N; Draper B; Ridley N; Gowing L; Stapinski L; Taye B; Lancaster K; Stjepanović D; Kay-Lambkin F; Jamshidi N; Lubman D; Pastor A; White N; Wilson S; Jaworski AL; Memedovic S; Logge W; Mills K; Seear K; Freeburn B; Lea T; Withall A; Marel C; Boffa J; Roxburgh A; Purcell-Khodr G; Doyle M; Conigrave K; Teesson M; Butler K; Connor J; Morley KC Med J Aust; 2021 Oct; 215 Suppl 7():S3-S32. PubMed ID: 34601742 [TBL] [Abstract][Full Text] [Related]
34. Pharmacological treatment of alcohol dependence: a review of the evidence. Garbutt JC; West SL; Carey TS; Lohr KN; Crews FT JAMA; 1999 Apr; 281(14):1318-25. PubMed ID: 10208148 [TBL] [Abstract][Full Text] [Related]
35. Deterrent Action of Acamprosate: A Case Report. Spoorthy MS; Godi S; Singh LK Addict Health; 2019 Oct; 11(4):276-280. PubMed ID: 32206220 [TBL] [Abstract][Full Text] [Related]
36. Gabapentin for Post-Hospitalization Alcohol Relapse Prevention; Should Gabapentin Be Considered for FDA Approval in the Treatment of Alcohol Use Disorder?: A Case Presentation and Literature Review. Rutkofsky IH; Fisher KA; Alvarez Villalba CL; Neuhut S Cureus; 2020 Jun; 12(6):e8931. PubMed ID: 32760631 [TBL] [Abstract][Full Text] [Related]
37. Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol? Richardson K; Baillie A; Reid S; Morley K; Teesson M; Sannibale C; Weltman M; Haber P Addiction; 2008 Jun; 103(6):953-9. PubMed ID: 18482418 [TBL] [Abstract][Full Text] [Related]
38. A randomized, double-blind, placebo-controlled clinical trial of acamprosate in alcohol-dependent individuals with bipolar disorder: a preliminary report. Tolliver BK; Desantis SM; Brown DG; Prisciandaro JJ; Brady KT Bipolar Disord; 2012 Feb; 14(1):54-63. PubMed ID: 22329472 [TBL] [Abstract][Full Text] [Related]
39. Daily associations between alcohol and sweets craving and consumption in early AUD recovery: Results from an ecological momentary assessment study. Abrantes AM; Kunicki Z; Braun T; Miranda R; Blevins CE; Brick L; Thomas G; Marsh E; Feltus S; Stein MD J Subst Abuse Treat; 2022 Jan; 132():108614. PubMed ID: 34493429 [TBL] [Abstract][Full Text] [Related]
40. The effect of acamprosate on alcohol craving and correlation with hypothalamic pituitary adrenal (HPA) axis hormones and beta-endorphin. Hammarberg A; Nylander I; Zhou Q; Jayaram-Lindström N; Reid MS; Franck J Brain Res; 2009 Dec; 1305 Suppl():S2-6. PubMed ID: 19799882 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]